Ending Normal Trade Relations with China Act of 2023

Ending Normal Trade Relations with China Act of 2023

This bill withdraws normal trade relations treatment (i.e., nondiscriminatory treatment) from China.

Further, the bill (1) sets the applicable duty rates on U.S. imports from China as the rates listed in column 2 of the U.S. Harmonized Tariff Schedule, and (2) authorizes the President to further increase the applicable duty rates.

These provisions become effective two years after the bill's enactment.

Bill 118 hr 4673, also known as the Ending Normal Trade Relations with China Act of 2023, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to terminate the normal trade relations status that the United States has with China.

If passed, this bill would have significant implications for the economic relationship between the two countries. Normal trade relations status allows for lower tariffs and other trade barriers between the US and China, making it easier for businesses in both countries to engage in trade. By ending this status, the US would be able to impose higher tariffs and other restrictions on Chinese imports.

Supporters of the bill argue that China engages in unfair trade practices, such as intellectual property theft and currency manipulation, that harm American businesses and workers. They believe that ending normal trade relations with China would help level the playing field and protect American interests. Opponents of the bill, on the other hand, argue that it could lead to a trade war between the US and China, which could have negative consequences for both countries' economies. They also point out that China is a major trading partner for the US, and ending normal trade relations could disrupt supply chains and increase prices for American consumers. Overall, the Ending Normal Trade Relations with China Act of 2023 is a controversial piece of legislation that has the potential to significantly impact the economic relationship between the US and China. It is currently being debated in Congress, and its outcome remains uncertain.